查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1356791

肝病診斷市場報告：至2030年的趨勢、預測與競爭分析

Liver Disease Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

肝病診斷藥物的發展趨勢與預測

預計到2030年，全球肝病診斷市場將達到 505 億美元，2024年至2030年年複合成長率為 6.2%。這個市場的主要促進因素是肝病盛行率的增加、酒精消費量的增加以及為患者進行準確和早期診斷而增加的研發支出。全球肝病診斷市場的未來充滿希望，醫院和研究機構市場存在商機。

肝病診斷市場洞察

Lucintel 預測，在預測期內，影像舉措仍將是最大的細分市場，因為肝病診斷市場的主要企業採取眾多措施來開發先進的影像技術。

由於住院人數的增加、先進診斷產品的可得性以及訓練有素的護理人員的存在，醫院仍然是該市場最大的區隔。

由於醫療保健支出增加、老年人口增加以及定期檢查意識增強，預計亞太地區將在預測期內實現最高成長。

本報告回答了 11 個關鍵問題：

  • Q.1.細分市場中最有前途和高成長的機會為何？
  • Q.2.哪個細分市場將以更快的速度成長？理由為何？
  • Q.3.哪些地區未來會出現更快的成長？理由為何？
  • Q.4.影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5.這個市場的商業風險和競爭威脅為何？
  • Q.6.這個市場有哪些新趨勢？理由為何？
  • Q.7.市場客戶需求有何改變？
  • Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10.該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球肝病診斷市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球肝病診斷市場趨勢（2018-2023）與預測（2024-2030）
  • 按診斷技術分類的全球肝病診斷市場
    • 成像
    • 臨床檢查
    • 內視鏡
    • 切片檢查
    • 其他
  • 全球肝病診斷市場（依最終用途）
    • 醫院
    • 實驗室
    • 其他

第4章 2018-2030年市場趨勢及預測分析（依地區）

  • 全球肝病診斷市場（依地區）
  • 北美肝病診斷市場
  • 歐洲肝病診斷市場
  • 亞太地區肝病診斷市場
  • 其他區域肝病診斷市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球肝病診斷市場成長機會（依診斷技術）
    • 全球肝病診斷市場成長機會（依最終用途）
    • 全球肝病診斷市場成長機會（依地區）
  • 全球肝病診斷市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球肝病診斷市場的產能
    • 全球肝病診斷市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Abbott
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Boston Scientific Corporation
  • Laboratory Corporation of America Holdings
  • Fujifilm Corporation
  • Horiba Medical
  • Siemens Healthcare
簡介目錄

Liver Disease Diagnostics Trends and Forecast

The future of the global liver disease diagnostics market looks promising with opportunities in the hospital and laboratoy markets. The global liver disease diagnostics market is expected to reach an estimated $50.5 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are increasing prevalence of liver diseases, rising alcohol consumption, and growing expenditure on research and development for accurate and early diagnosis of patients.

A more than 150-page report is developed to help in your business decisions.

Liver Disease Diagnostics by Segment

The study includes a forecast for the global liver disease diagnostics by diagnosis technique, end use, and region.

Liver Disease Diagnostics Market by Diagnosis Technique [Shipment Analysis by Value from 2018 to 2030]:

  • Imaging
  • Laboratory tests
  • Endoscopy
  • Biopsy
  • Others

Liver Disease Diagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Laboratories
  • Others

Liver Disease Diagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Liver Disease Diagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies liver disease diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the liver disease diagnostics companies profiled in this report include-

  • Abbott
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Boston Scientific Corporation
  • Laboratory Corporation Of America Holdings
  • Fujifilm Corporation
  • Horiba Medical
  • Siemens Healthcare

Liver Disease Diagnostics Market Insights

Lucintel forecasts that imaging will remain the largest segment over the forecast period due to the growing number of initiatives taken by key players in the market for liver disease diagnostics so as to develop advanced imaging techniques.

Within this market, hospitals will remain the largest segment due to growing admission of patient, availability of advanced diagnostic products, and presence of well-trained nursing staff.

APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, growing geriatric population, and rising awarness towards regular checkups in the region.

Features of the Global Liver Disease Diagnostics Market

Market Size Estimates: Liver disease diagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Liver disease diagnostics market size by diagnosis technique, end use, and region. in terms of value ($B).

Regional Analysis: Liver disease diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnosis techniques, end uses, and region.s for the liver disease diagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the liver disease diagnostics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the liver disease diagnostics market size?

Answer: The global liver disease diagnostics market is expected to reach an estimated $50.5 billion by 2030.

Q.2. What is the growth forecast for liver disease diagnostics market?

Answer: The global liver disease diagnostics market is expected to grow with a CAGR of 6.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the liver disease diagnostics market?

Answer: The major drivers for this market are increasing prevalence of liver diseases, rising alcohol consumption, and growing expenditure on research and development for accurate and early diagnosis of patients.

Q.4. What are the major segments for liver disease diagnostics market?

Answer: The future of the liver disease diagnostics market looks promising with opportunities in the hospitals and laboratories markets.

Q.5. Who are the key liver disease diagnostics market companies?

Answer: Some of the key liver disease diagnostics companies are as follows:

  • Abbott
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Boston Scientific Corporation
  • Laboratory Corporation of America Holdings
  • Fujifilm Corporation
  • Horiba Medical
  • Siemens Healthcare

Q.6. Which liver disease diagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that imaging will remain the largest segment over the forecast period due to the growing number of initiatives taken by key players in the market for liver disease diagnostics so as to develop advanced imaging techniques.

Q.7. In liver disease diagnostics market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, growing geriatric population, and rising awarness towards regular checkups in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the liver disease diagnostics market by diagnosis technique (imaging, laboratory tests, endoscopy, biopsy, and others), end use (hospitals, laboratories, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Liver Disease Diagnostics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Liver Disease Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Liver Disease Diagnostics Market by Diagnosis Technique
    • 3.3.1: Imaging
    • 3.3.2: Laboratory tests
    • 3.3.3: Endoscopy
    • 3.3.4: Biopsy
    • 3.3.5: Others
  • 3.4: Global Liver Disease Diagnostics Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Laboratories
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Liver Disease Diagnostics Market by Region
  • 4.2: North American Liver Disease Diagnostics Market
    • 4.2.2: North American Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others
  • 4.3: European Liver Disease Diagnostics Market
    • 4.3.1: European Liver Disease Diagnostics Market by Diagnosis Technique: Imaging, Laboratory Tests, Endoscopy, Biopsy, and Others
    • 4.3.2: European Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others
  • 4.4: APAC Liver Disease Diagnostics Market
    • 4.4.1: APAC Liver Disease Diagnostics Market by Diagnosis Technique: Imaging, Laboratory Tests, Endoscopy, Biopsy, and Others
    • 4.4.2: APAC Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others
  • 4.5: ROW Liver Disease Diagnostics Market
    • 4.5.1: ROW Liver Disease Diagnostics Market by Diagnosis Technique: Imaging, Laboratory Tests, Endoscopy, Biopsy, and Others
    • 4.5.2: ROW Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Liver Disease Diagnostics Market by Diagnosis Technique
    • 6.1.2: Growth Opportunities for the Global Liver Disease Diagnostics Market by End Use
    • 6.1.3: Growth Opportunities for the Global Liver Disease Diagnostics Market by Region
  • 6.2: Emerging Trends in the Global Liver Disease Diagnostics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Liver Disease Diagnostics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Liver Disease Diagnostics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Thermo Fisher Scientific
  • 7.4: Randox Laboratories
  • 7.5: Boston Scientific Corporation
  • 7.6: Laboratory Corporation of America Holdings
  • 7.7: Fujifilm Corporation
  • 7.8: Horiba Medical
  • 7.9: Siemens Healthcare